Innovent Biologics Technology Limited (Shanghai R&D Center)
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Innovent Biologics Technology Limited (Shanghai R&D Center)
RECRUITINGPhase 3NCT07414394
Tigulixostat (IBI128) vs Febuxostat in Gout
The primary purpose of this study is to compare the efficacy of Tigulixostat (IBI128) versus Febuxostat on the proportion of Chinese adults with gout achieving a serum uric acid...
Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center)Enrolling: 6001 location
Gout
RECRUITINGPhase 2NCT07275840
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
This study is designed for Open-label, multi-center, single-arm Phase II trail to evaluate the efficacy and safety of intravitreal injection of IBI302 in nAMD patients.
Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center)Enrolling: 8001 location
Neovascular Age-related Macular Degeneration